Data Shows Minimally Invasive Treatment Provides Rapid Symptom Relief, Allowing Men to Return to Daily Activities Quickly WAYNE, Pa., June 22, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX ...
The committee concluded that the evidence from the Rezum II study demonstrated the effectiveness of Rezum in relieving lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia ...
The review article titled“Sexual dysfunction after Rezum therapy for benign prostatic hyperplasia: A scoping review for the current insights and findings”, was published on December 10, 2024 in ...
Four studies were relevant to the decision problem in the scope: 1 randomised controlled trial (5 publications: McVary et al. 2019, McVary and Roehrborn 2018, Roehrborn et al. 2017, McVary et al.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback